barr 882 (Hydroxyurea 500 mg)

Pill with imprint barr 882 is Pink & Purple, Capsule-shape and has been identified as Hydroxyurea 500 mg. It is supplied by Teva Pharmaceuticals USA.

Hydroxyurea is used in the treatment of chronic myelogenous leukemia; anemia, sickle cell; solid tumors and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Hydroxyurea 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for barr 882

Hydroxyurea

Imprint: barr 882
Strength: 500 mg
Color: Pink & Purple
Size: 22.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Antimetabolites
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: Teva Pharmaceuticals USA
Inactive Ingredients: citric acid anhydrous, benzyl alcohol, ferrosoferric oxide, butylparaben, D&C Red No. 28, D&C Yellow No. 10, sodium phosphate dibasic, edetate calcium disodium, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, gelatin, lactose monohydrate, magnesium stearate, methylparaben, shellac, propylparaben sodium, propylene glycol, ferric oxide red, sodium lauryl sulfate, sodium propionate, titanium dioxide
Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
00555-0882	Barr Laboratories, Inc.
42291-0321	AvKare, Inc.
54868-4773	Physicians Total Care Inc. (repackager)
54569-5715	A-S Medication Solutions, LLC (repackager)